Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Incyte Corp. | 13 | 2 | 0 | 0 | €56.94 | €77.67 | 36.409% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 4 | 0 | €1,039.0 | €1,085.0 | 4.432% |
| Exact Sciences | 18 | 0 | 1 | 0 | €54.36 | €76.01 | 39.834% |
| Johnson & Johnson | 40 | 1 | 2 | 0 | €150.78 | €194.53 | 29.017% |
| Amgen Inc. | 28 | 0 | 0 | 0 | €296.30 | €304.73 | 2.846% |
| Pfizer Inc. | 31 | 4 | 6 | 0 | €26.69 | €41.10 | 54.001% |
| Gilead Sciences Inc | 10 | 0 | 1 | 0 | €71.75 | €84.47 | 17.729% |
| AbbVie Inc. | 34 | 0 | 2 | 0 | €177.88 | €180.90 | 1.700% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €115.65 | €130.00 | 12.408% |
| Eli Lilly Corp. | 69 | 0 | 10 | 0 | €817.80 | €829.73 | 1.459% |
| Merck & Co. Inc. | 31 | 1 | 1 | 0 | €104.20 | €125.78 | 20.710% |
| Abbott Laboratories | 20 | 0 | 2 | 0 | €105.26 | €116.25 | 10.439% |
| Vertex Pharmaceuticals Inc. | 57 | 2 | 0 | 0 | €427.25 | €440.14 | 3.016% |